176 results on '"Severens,Johan L"'
Search Results
2. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke
3. Impact of hospitalisation on health-related quality of life in patients with chronic heart failure
4. Economic Evaluation of Implementation Strategies
5. European survey on acute coronary syndrome diagnosis and revascularisation treatment: Assessing differences in reported clinical practice with a focus on strategies for specific patient cases
6. Adverse events associated with bone-conduction and middle-ear implants: a systematic review
7. TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility
8. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom
9. Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening
10. What stroke image do we want? European survey on acute stroke imaging and revascularisation treatment
11. Value of information analysis in telehealth for chronic heart failure management
12. A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa–coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon
13. Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report
14. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management
15. Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication
16. Integrating clinical and economic evidence in clinical guidelines: More needed than ever!
17. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease
18. Health care input constraints and cost effectiveness analysis decision rules
19. What are the images used to diagnose and assess suspected strokes?: A systematic literature review of care in four European countries
20. Early warning systems for the management of chronic heart failure: a systematic literature review of cost-effectiveness models
21. Care coordination in a business-to-business and a business-to-consumer model for telemonitoring patients with chronic diseases
22. Assessment of a Business-to-Consumer (B2C) model for Telemonitoring patients with Chronic Heart Failure (CHF)
23. Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists
24. Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
25. The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
26. Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries
27. Patients’ preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists
28. Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
29. Reply to T. Magnes et al
30. Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort
31. Productivity Loss Related to Neglected Tropical Diseases Eligible for Preventive Chemotherapy: A Systematic Literature Review
32. Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis
33. Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results – a case study
34. Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study
35. Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia
36. Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene
37. Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review
38. Early cost‐utility analysis of general and cerebrospinal fluid‐specific Alzheimer's disease biomarkers for hypothetical disease‐modifying treatment decision in mild cognitive impairment
39. The influence of preferred place of birth on the course of pregnancy and labor among healthy nulliparous women: a prospective cohort study
40. Ocular Hypertension and the Risk of Blindness
41. REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE
42. A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
43. Economic evaluation of implementation strategies in health care
44. Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes
45. Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method
46. Cost–effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
47. O4-13-01: COST-UTILITY OF ALZHEIMER'S DISEASE BIOMARKERS
48. The Effect of Presenting Information about Invasive Follow-Up Testing on Individuals’ Noninvasive Colorectal Cancer Screening Participation Decision: Results from a Discrete Choice Experiment
49. Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis
50. High-sensitive Troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.